Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 8

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 8
---
 able to attend the Special Meeting in person. You may attend the Special Meeting via the internet, vote your
securities during the Special Meeting and submit questions at the appropriate times during the Special Meeting.

An independent transaction committee (the “Transaction Committee”) of the Board has advised the Board that, after careful consideration, including, among other things, thorough consideration of (i)the process undertaken by the Company, over several months, to explore strategic alternatives to maximize Shareholder value; (ii)the strategic alternatives and options available to the Company, including the prospects of the Company on a standalone basis and the expected return to Shareholders if the Company were to be liquidated and the Company’s conclusion that none of the potential parties contacted during the Company’s process to explore strategic alternatives offered a transaction that the Company considered more advantageous to Shareholders than the Arrangement; (iii)the terms and conditions of the Agreement; (iv)the benefits and risks associated with the Arrangement; (v)the impact of the Arrangement on the Shareholders and other stakeholders of the Company; (vi)advice from management and its legal and financial advisors; and (vii) the opinion of Leerink Partners dated November14, 2025, that, as of such date and based upon and subject to the various assumptions made, and the qualifications and limitations upon the review undertaken by Leerink Partners in preparing its opinion, the cash consideration to be received by the Shareholders (other than holders of Excluded Shares) pursuant to the Arrangement is fair, from a financial point of view, to the Shareholders, the Transaction Committee unanimously determined that the Consideration to be received by the Shareholders (other than holders of Excluded Shares) pursuant to the Arrangement is fair to the Shareholders, that the Arrangement is in the best interests of the Company, and unanimously recommended to the Board that it approve the Agreement and recommend that the Shareholders vote in favour of the Arrangement Resolution.

After taking into consideration, among other things, the factors enumerated in the preceding paragraph and the unanimous recommendation of the Transaction Committee, the Board has concluded that the Arrangement is in the best interests of the Company and has approved the Arrangement and authorized its submission to the Shareholders. Accordingly, the Board unanimously recommends that Shareholders vote FOR the Arrangement Resolution. It is a condition to the completion of the Arrangement that the Arrangement Resolution be approved by Shareholders at the Special Meeting.

It is a condition to the completion of the Arrangement that the
Arr